Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results
Rhea-AI Summary
Embecta (Nasdaq: EMBC) reported second quarter fiscal 2026 financial results and announced an analyst and investor conference call and live webcast on May 5, 2026 at 8:00 a.m. ET. A webcast replay will be available beginning at 11:00 a.m. ET on May 5, 2026 and archived for one year on the investor website.
Investors are directed to the company investor relations site for the full earnings press release and presentation.
Positive
- None.
Negative
- None.
News Market Reaction – EMBC
On the day this news was published, EMBC declined 57.84%, reflecting a significant negative market reaction. Argus tracked a trough of -59.3% from its starting point during tracking. Our momentum scanner triggered 104 alerts that day, indicating very high trading interest and price volatility. This price movement removed approximately $752M from the company's valuation, bringing the market cap to $547.78M at that time. Trading volume was exceptionally heavy at 22.1x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | Q1 2026 earnings | Neutral | -7.8% | Reported Q1 FY2026 results and hosted earnings call and webcast. |
| Nov 25 | FY2025 results | Negative | -7.2% | Reported Q4 and FY2025 results with revenue declines and issued FY2026 guidance. |
| Aug 08 | Q3 2025 earnings | Positive | +18.5% | Strong Q3 FY2025 growth, higher EPS, debt reduction and guidance raise. |
| May 09 | Q2 2025 earnings | Negative | -10.0% | Q2 FY2025 revenues declined while margins improved and dividend maintained. |
| Feb 06 | Q1 2025 earnings | Neutral | -2.6% | Q1 FY2025 results with revenue decline but slightly higher adjusted EPS and solid liquidity. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases have typically produced modestly negative average moves of about -1.81%, with one notably strong positive reaction and several declines when revenues softened or guidance reset.
Over the past year, embecta has used earnings updates to communicate its transition and financial trajectory. Q1 FY2025 and Q2 FY2025 showed revenue declines but stable or improving profitability and ongoing dividends. Q3 FY2025 delivered stronger growth and a sizable positive price reaction. FY2025 year-end results and FY2026 guidance then drew a negative response as revenues fell year-over-year. The most recent Q1 FY2026 earnings on Feb 5, 2026 saw a -7.75% move. Today’s Q2 FY2026 release continues this sequence of regular earnings communications.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported second quarter fiscal 2026 financial results.
Visit the company’s Investor Relations website at http://investors.embecta.com to view the detailed second quarter fiscal 2026 earnings press release and investor presentation.
The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, May 5, 2026, which is accessible here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on May 5, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
